Conexeu Sciences is trading at $5.57 (-5.11%), with no company-specific September 2 announcement or filing explaining the decline.
- The stock fell 18.19% on September 1.
- An August 31 Form D disclosed $88,548 of securities issued as consulting-service payments, including 11,759 shares; no source directly links it to today’s selling.
- Biotech is up 2.75%, so sector strength does not explain the weakness.